EU Mpox Vaccine Contracts Under Scrutiny

Advocates are calling on the European Union to release full details of its contracts for the mpox vaccine, arguing that the partially disclosed information hinders global vaccine access discussions led by the WHO. The Commission’s decision to only publish a redacted version raises concerns about transparency and equitable distribution of the vaccine. This situation underscores the ongoing challenges in securing sufficient vaccine supplies for international health emergencies.

Summarized from the sources above. Read the originals for the full story.